Rheumatoid arthritis trials in United Kingdom

In United Kingdom 16 Also abroad 351

16 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
A Study of AZD0120 in Autoimmune Diseases
Where
Edinburgh, London
Age
18 years to 75 years
People
27 worldwide
Run by
AstraZeneca
See details and how to joinNCT07295847
Phase 1Taking people
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Where
London
Age
18 years to 65 years
People
48 worldwide
Run by
AstraZeneca
See details and how to joinNCT07201558 · EU 2025-522273-10-00
Phase 1Taking people
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Where
Glasgow, London, Southampton
Age
18 years to 70 years
People
72 worldwide
Run by
AstraZeneca
See details and how to joinNCT06916806 · EU 2024-519015-34-00
Phase 1/2Taking people
Controlling Hyperactive Immunity With Long-lived Lymphocytes
Where
Birmingham, Leeds, London, Manchester, Newcastle, Oxford
Age
18 years and over
People
16 worldwide
Run by
Quell Therapeutics Limited
See details and how to joinNCT07473154
Phase 2Taking people
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
Where
Barnet, Doncaster, Leicester, Newcastle upon Tyne
Age
18 years and over
People
160 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07137598
No phaseTaking people
The Medacta International SMS Post-Marketing Surveillance Study
Where
Epsom
Age
18 years to 75 years
People
550 worldwide
Run by
Medacta International SA
See details and how to joinNCT02748408
Phase 2Taking people
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Where
Glasgow, Leeds, Luton, Staffordshire
Age
18 years and over
People
320 worldwide
Run by
AstraZeneca
See details and how to joinNCT07276581
Phase 2Taking people
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Where
Cambridge, Edinburgh, Leicester, Newcastle upon Tyne
Age
18 years to 75 years
People
220 worldwide
Run by
Amgen
See details and how to joinNCT06570798
No phaseTaking people
Exactech Shoulder Post Market Clinical Follow-up Study
Where
Bath, Bedford, Ipswich, Leicester, Manchester, Nottingham, Reading, Yeovil
Age
21 years and over
People
20,000 worldwide
Run by
Exactech
See details and how to joinNCT05603728
No phaseTaking people
Clinical Outcomes Study of the Nexel Total Elbow
Where
Wigan
Age
18 years and over
People
134 worldwide
Run by
Zimmer Biomet
See details and how to joinNCT02469662
No phaseTaking people
BloodTrackR Usability and Concordance Study (BUCS): Evaluating a Smart Home-Based Blood Collection Platform for Remote Monitoring in Rheumatoid Arthritis
Where
Londonderry
Age
18 years and over
People
20
Run by
University of Ulster
See details and how to joinNCT07660029
No phaseTaking people
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
Where
Nottingham
Age
18 years and over
People
600 worldwide
Run by
Aesculap AG
See details and how to joinNCT05302934
No phaseTaking people
Neurofeedback for Nociplastic Pain in Rheumatoid Arthritis (NECTAR)
Where
Glasgow
Age
18 years to 75 years
People
16
Run by
NHS Greater Glasgow and Clyde
See details and how to joinNCT06240299
No phaseTaking people
EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality
Where
Wolverhampton
Age
6 years and over
People
200,000
Run by
Future Genetics Limited
See details and how to joinNCT03987633
No phaseTaking people
7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of Analgesic Action in Rheumatoid Arthritis
Where
Glasgow
Age
18 years to 74 years
People
20
Run by
NHS Greater Glasgow and Clyde
See details and how to joinNCT05697159
No phaseTaking people
Safety of Splenic Stimulation for RA
Where
Glasgow
Age
22 years to 75 years
People
5 worldwide
Run by
Galvani Bioelectronics
See details and how to joinNCT04955899